These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8712120)

  • 21. Reduction in left ventricular mass in patients with systemic hypertension treated with enalapril, lisinopril, or fosenopril.
    Oren S; Grossman E; Frohlich ED
    Am J Cardiol; 1996 Jan; 77(1):93-6. PubMed ID: 8540468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Centralized echocardiogram quality control in a multicenter study of regression of left ventricular hypertrophy in hypertension.
    Gosse P; Guez D; Guéret P; Dubourg O; Beauchet A; de Cordoüe A; Barrandon S
    J Hypertens; 1998 Apr; 16(4):531-5. PubMed ID: 9797199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ACE inhibitors captopril and enalapril induce regression of left ventricular hypertrophy in hypertensive patients with chronic renal failure.
    Dyadyk AI; Bagriy AE; Lebed IA; Yarovaya NF; Schukina EV; Taradin GG
    Nephrol Dial Transplant; 1997 May; 12(5):945-51. PubMed ID: 9175047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Left ventricular midwall function improves with antihypertensive therapy and regression of left ventricular hypertrophy in patients with asymptomatic hypertension.
    Schussheim AE; Diamond JA; Phillips RA
    Am J Cardiol; 2001 Jan; 87(1):61-5. PubMed ID: 11137835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects of felodipine and nifedipine on 24-h blood pressure and left ventricular mass.
    Myers MG; Leenen FH; Tanner J
    Am J Hypertens; 1995 Jul; 8(7):712-8. PubMed ID: 7546497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of nitrendipine and enalapril on left ventricular mass in patients with non-insulin-dependent diabetes mellitus and hypertension.
    Gerritsen TA; Bak AA; Stolk RP; Jonker JJ; Grobbee DE
    J Hypertens; 1998 May; 16(5):689-96. PubMed ID: 9797181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative effects of fosinopril and nifedipine on regression of left ventricular hypertrophy in hypertensive patients: a double-blind study.
    Kirpizidis HG; Papazachariou GS
    Cardiovasc Drugs Ther; 1995 Feb; 9(1):141-3. PubMed ID: 7786834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of long-term eprosartan versus enalapril antihypertensive therapy on left ventricular mass and coronary flow reserve in stage I-II hypertension. Eprosartan Study Group.
    Diamond JA; Gharavi A; Roychoudhury D; Machac J; Henzlova MJ; Travis A; Phillips RA
    Curr Med Res Opin; 1999; 15(1):1-8. PubMed ID: 10216805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Change of left ventricular geometric pattern after 1 year of antihypertensive treatment: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
    Wachtell K; Dahlöf B; Rokkedal J; Papademetriou V; Nieminen MS; Smith G; Gerdts E; Boman K; Bella JN; Devereux RB
    Am Heart J; 2002 Dec; 144(6):1057-64. PubMed ID: 12486431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study population and treatment titration in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT).
    Brown MJ; Castaigne A; de Leeuw PW; Mancia G; Rosenthal T; Ruilope LM
    J Hypertens; 1998 Dec; 16(12 Pt 2):2113-6. PubMed ID: 9886905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effects of chronic oral antihypertensive therapies on systemic arterial circulation and ventricular energetics in African-American patients.
    Cholley BP; Shroff SG; Sandelski J; Korcarz C; Balasia BA; Jain S; Berger DS; Murphy MB; Marcus RH; Lang RM
    Circulation; 1995 Feb; 91(4):1052-62. PubMed ID: 7850941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maintenance of blood pressure control and left ventricular performance with small doses of enalapril.
    González-Juanatey JR; Reino AP; García-Acuña JM; González-Juanatey C; Valdes L; de la Peña MG; Cabezas-Cerrato J
    Am J Cardiol; 1999 Mar; 83(5):719-23. PubMed ID: 10080425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Underestimation of 24-hour hypotensive efficacy of nifedipine GITS versus enalapril: ambulatory recording as an adjunct to clinical blood pressure measurement.
    Schulte KL; Lenz T; Fischer M; Meyer-Sabellek W; Gotzen R
    Blood Press; 2000; 9(4):221-6. PubMed ID: 11055475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison study of the echocardiographic changes in hypertensive patients treated with telmisartan vs. enalapril.
    Hadi NR; Abdulzahra MS; Al-Huseini LM; Al-Aubaidy HA
    Int J Cardiol; 2017 Mar; 230():269-274. PubMed ID: 28041700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of very low dose perindopril 2 mg/indapamide 0.625 mg combination on left ventricular hypertrophy in hypertensive patients: the P.I.C.X.E.L. study rationale and design.
    Gosse P; Dubourg O; Guéret P; De Simone G; Schmieder R; De Leeuw PW; Degaute JP; García Puig J; Karpov Y; Magometschnigg D; Matos L; Amouyel P; Asmar R; Le Heuzey JY; Nieminen M; Dahlöf B
    J Hum Hypertens; 2002 Sep; 16(9):653-9. PubMed ID: 12214263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The effect of nifedipine in hypertensive cardiopathy. An echocardiographic and electrocardiographic study].
    Sau F; Seguro C; Lai C; Onnis E; Orani E; Soro A; Leo MR; Cherchi A
    Cardiologia; 1993 Jun; 38(6):369-76. PubMed ID: 8402746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversal of left ventricular hypertrophy: what have recent trials taught us?
    Verdecchia P; Angeli F
    Am J Cardiovasc Drugs; 2004; 4(6):369-78. PubMed ID: 15554722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correction of hypertensive cardiac remodelling: comparison of different antihypertensive therapies.
    Almazov VA; Shlyakhto EV; Konrady AO; Macsimova TA; Zaharov DV; Rudomanov OG
    Med Sci Monit; 2000; 6(2):309-13. PubMed ID: 11208328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential protective effect of long-term therapy with Xuezhikang on left ventricular diastolic function in patients with essential hypertension.
    Ye P; Wu CE; Sheng L; Li H
    J Altern Complement Med; 2009 Jul; 15(7):719-25. PubMed ID: 19552598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regression of left ventricular hypertrophy with long-term treatment of nifedipine in systemic hypertension.
    Yamakado T; Teramura S; Oonishi T; Maeda M; Nakano T
    Clin Cardiol; 1994 Nov; 17(11):615-8. PubMed ID: 7834936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.